The efficacy and safety of rilzabrutinib in patients aged 10 to 65 years with sickle-cell disease (LIBRA)
Clinical Trial Grant
Administered By
Medicine, Hematology
Awarded By
Sanofi US Services, Inc.
Start Date
May 18, 2026
End Date
November 30, 2030
Administered By
Medicine, Hematology
Awarded By
Sanofi US Services, Inc.
Start Date
May 18, 2026
End Date
November 30, 2030